ClinicalTrials.gov
ClinicalTrials.gov Menu

Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00006263
Recruitment Status : Withdrawn
First Posted : January 27, 2003
Last Update Posted : August 5, 2015
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
New York University School of Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : No date given
  Study Completion Date : No date given